 |
|
|
|
PROCYTE CORPORATION ANNOUNCES CONFERENCE CALL TO DISCUSS 2003
YEAR END FINANCIAL RESULTS
Redmond, Wash.—February 27, 2004—ProCyte Corporation (OTCBB: PRCY.OB),
a company that develops and markets skin care and therapeutic products for the
dermatology, cosmetic surgery and spa markets, today announced
that it will release its fourth quarter and year end financial results on Thursday, March 4,
2004, with a conference call scheduled for 11:00 a.m. Eastern Time that
same day. To participate, please dial 1-800-294-4202 ten minutes before
the call is scheduled to begin and the participant code is 39046#. For
those unable to participate in the live conference call, a replay will
be available beginning March 4th and ending on Monday, March 8, 2004.
Please call 1-888-844-1786 between 8:00 a.m. and 9:00 p.m. Eastern and
request Code 152021# for the replay.
ProCyte Corporation develops and markets products based on its patented,
clinically proven copper peptide technology for skin health, hair care
and wound care. The Company sells directly to dermatologists, plastic
and cosmetic surgeons, spas and through licenses with strategic partners
into the consumer market, including its long-term worldwide license
agreement with Neutrogena®, a Johnson & Johnson company.
ProCyte’s products include Neova®, VitalCopper™, Simple
Solutions®
and AquaSanté® Skin Care products; Complex Cu3®
Post-Procedure Skin Care; GraftCyte® Hair Transplant Care;
and Tricomin® Advanced Care for Thinning Hair. The Company
also has the exclusive distribution rights for Cutanix Corporation’s
Quadrinone® technology for medical and spa markets in the
U.S., Canada and Puerto Rico. Additional information is available by
visiting the Company’s website at www.procyte.com and www.vitalcopper.com.
###
This release may contain forward-looking statements relating to the
research, development, commercialization, production, marketing and
distribution of the Company's products and future operating results,
which are subject to certain risks and uncertainties that could cause
actual results to differ materially from those projected.
The
words “believe,” “expect,” “intend,” “anticipate,” variations of such
words, and similar expressions
identify forward-looking statements, but their absence does not mean
that the statement is not forward-looking. These statements are not
guarantees of future performance and are subject to certain risks,
uncertainties and assumptions that are difficult to predict. Factors
that could affect the Company’s actual results include its ability to
develop, commercialize and produce new products; the market acceptance
of existing and potential future products; the availability, cost and
timely delivery of materials and services from and performance of
third-party suppliers, manufacturers, distributors, licensees and other
collaborative partners; the satisfaction of regulatory requirements, and
the receipt, timing, terms and conditions of required regulatory
approvals. Reference is made to the Company’s Annual Report on Form
10-K for the year ended December 31, 2002 and its latest Quarterly
Report on Form 10-Q filed with the Securities and Exchange Commission
for a more detailed description of such factors. Readers are cautioned
not to place undue reliance on these forward-looking statements, which
speak only as of the date of this release. The Company undertakes no
obligation to publicly update any forward-looking statement to reflect
new information, events or circumstances after the date of this release
or to reflect the occurrence of unanticipated events. |
|
|
|
